Page 263 - Binder2

4.11 Conclusion: When Biology Becomes
Infrastructure

For more than a century, medicine has followed a familiar
blueprint:
Design the molecule.
Build the factory.
Ship the vial.
Inject the patient.

It’s a model that changed the world—but it wasn’t built for
the one we live in now.

Today’s global health reality demands something different:
Therapies that are resilient, affordable, accessible, and
immunologically sound.
Drugs that don’t just work—but stay working, without
provoking rejection.
Delivery models that don’t depend on steel tanks, cold
trucks, or clinic chairs.
A future where biology isn’t just manufactured—it’s
grown.

This is the promise of edible biologics.

Not as a gimmick.
Not as a fringe delivery format.
But as infrastructure—a foundational system for
producing, distributing, and administering therapeutics in a
post-industrial world.

We’ve already seen what happens when biology becomes
software.
We’re now seeing what happens when biology becomes
code.
The next evolution is when biology becomes

261